Home › Therapeutic areas › Oncology › Mesothelioma
Mesothelioma (3 companies)
Companies with an active program in Mesothelioma.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| CMPX | Compass Therapeutics | Oncology | 1 | Phase 2 | $137M | 15 |
| NVCT | Nuvectis Pharma | HematologyOncology+1 Rare | 1 | Phase 3 | $719M | 9 |
| SLS | SELLAS Life Sciences Group | Oncology | 1 | Phase 3 | $1.70B | 9 |
No companies match.